Relative Potency of Inhaled Corticosteroids

NCT00292838 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Asthma
Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: fluticasone 25, 50, 100, 200 mcg

Sponsor

St. Joseph's Healthcare Hamilton

Collaborators

[object Object]